Plasma lipid parameters, CET, and CETP concentration in type 2 diabetic patients and control subjects
| . | Type 2 diabetic subjects (n = 87) . | . | Control subjects (n = 82) . | . | P value . | ||
|---|---|---|---|---|---|---|---|
| . | Male . | Female . | Male . | Female . | . | ||
| n | 53 | 34 | 45 | 37 | 0.43 | ||
| Plasma total cholesterol (mmol/l) | 5.2 ± 0.9 | 5.6 ± 0.8* | 5.6 ± 1.0 | 5.8 ± 0.8 | 0.008 | ||
| Non-HDL cholesterol (mmol) | 3.87 ± 0.96 | 4.16 ± 0.90 | 4.16 ± 1.03 | 3.98 ± 0.79 | 0.51 | ||
| HDL cholesterol (mmol/l) | 1.28 ± 0.33 | 1.46 ± 0.37* | 1.49 ± 0.36 | 1.82 ± 0.41† | <0.001 | ||
| Plasma triglycerides (mmol/l) | 1.82 (0.97–2.46) | 1.64 (1.26–2.15) | 1.34 (0.94–2.07) | 1.21 (0.86–1.73) | 0.008 | ||
| Plasma apoA-I (g/l) | 1.26 ± 0.17 | 1.43 ± 0.28† | 1.36 ± 0.21 | 1.53 ± 0.22† | 0.001 | ||
| Plasma apoB (g/l) | 0.90 ± 0.20 | 0.96 ± 0.22 | 0.99 ± 0.26 | 0.90 ± 0.19 | 0.49 | ||
| Plasma CET (nmol · ml−1 · h−1) | 23.3 ± 8.1 | 25.0 ± 9.5 | 20.6 ± 7.3 | 19.7 ± 4.7 | 0.001 | ||
| Plasma CETP concentration (mg/l) | 2.36 ± 0.83 | 2.90 ± 0.99* | 2.16 ± 0.68 | 2.17 ± 0.65 | 0.001 | ||
| . | Type 2 diabetic subjects (n = 87) . | . | Control subjects (n = 82) . | . | P value . | ||
|---|---|---|---|---|---|---|---|
| . | Male . | Female . | Male . | Female . | . | ||
| n | 53 | 34 | 45 | 37 | 0.43 | ||
| Plasma total cholesterol (mmol/l) | 5.2 ± 0.9 | 5.6 ± 0.8* | 5.6 ± 1.0 | 5.8 ± 0.8 | 0.008 | ||
| Non-HDL cholesterol (mmol) | 3.87 ± 0.96 | 4.16 ± 0.90 | 4.16 ± 1.03 | 3.98 ± 0.79 | 0.51 | ||
| HDL cholesterol (mmol/l) | 1.28 ± 0.33 | 1.46 ± 0.37* | 1.49 ± 0.36 | 1.82 ± 0.41† | <0.001 | ||
| Plasma triglycerides (mmol/l) | 1.82 (0.97–2.46) | 1.64 (1.26–2.15) | 1.34 (0.94–2.07) | 1.21 (0.86–1.73) | 0.008 | ||
| Plasma apoA-I (g/l) | 1.26 ± 0.17 | 1.43 ± 0.28† | 1.36 ± 0.21 | 1.53 ± 0.22† | 0.001 | ||
| Plasma apoB (g/l) | 0.90 ± 0.20 | 0.96 ± 0.22 | 0.99 ± 0.26 | 0.90 ± 0.19 | 0.49 | ||
| Plasma CET (nmol · ml−1 · h−1) | 23.3 ± 8.1 | 25.0 ± 9.5 | 20.6 ± 7.3 | 19.7 ± 4.7 | 0.001 | ||
| Plasma CETP concentration (mg/l) | 2.36 ± 0.83 | 2.90 ± 0.99* | 2.16 ± 0.68 | 2.17 ± 0.65 | 0.001 | ||
Data are means ± SD or median (interquartile range). P values for the difference between type 2 diabetic patients (male and female subjects combined) and control subjects (male and female subjects combined) are shown. Within-group difference between male and female subjects:
P < 0.05,
P < 0.001.